|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.58 USD | 0.00% |
|
-3.35% | -12.31% |
| 05-13 | Supernus Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:40 PM | |
| 05-05 | Supernus Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 05, 2026 |
| Market Cap | 2.53B 2.18B 2.01B 1.89B 3.55B 239B 3.58B 23.77B 9.26B 117B 9.49B 9.29B 405B | P/E 2026 * |
101x | P/E 2027 * | 30.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.53B 2.18B 2.01B 1.89B 3.55B 239B 3.58B 23.77B 9.26B 117B 9.49B 9.29B 405B | EV / Sales 2026 * |
2.92x | EV / Sales 2027 * | 2.48x |
| Free-Float |
95.54% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Supernus Pharmaceuticals, Inc.
| 1 week | -3.35% | ||
| Current month | -5.63% | ||
| 1 month | -11.83% | ||
| 3 months | -14.25% | ||
| 6 months | -10.61% | ||
| Current year | -12.31% |
| 1 week | 42.45 | 45.71 | |
| 1 month | 42.45 | 49.83 | |
| Current year | 42.45 | 59.68 | |
| 1 year | 30.83 | 59.68 | |
| 3 years | 21.99 | 59.68 | |
| 5 years | 21.99 | 59.68 | |
| 10 years | 13.12 | 61.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jack Khattar
CEO | Chief Executive Officer | 64 | 2005-12-21 |
Timothy Dec
DFI | Director of Finance/CFO | 67 | 2021-08-22 |
Frank Mottola
CTO | Chief Tech/Sci/R&D Officer | 54 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jack Khattar
BRD | Director/Board Member | 64 | 2005-12-21 |
Charles Newhall
CHM | Chairman | 80 | 2016-08-09 |
Frederick Hudson
BRD | Director/Board Member | 80 | 2010-11-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-15 | Fiscal year | Chief Technology Officer | 321,750 | 0.5738% | ||
| 03-12 | Others | Founder | 60,000 | 0.1070% | ||
| 03-11 | Sell | Director | 5,369 | 0.0096% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -3.35% | +34.82% | +29.05% | 2.53B | ||
| +0.23% | -3.06% | +47.47% | +5.60% | 284B | ||
| +1.02% | -2.24% | +19.00% | -19.76% | 66.62B | ||
| -1.54% | -2.74% | +29.11% | +96.03% | 8.26B | ||
| +1.49% | +4.14% | +0.02% | -10.26% | 7.84B | ||
| +1.92% | -1.63% | -1.63% | +5.36% | 4.6B | ||
| +1.02% | +3.13% | -25.59% | +41.73% | 3.87B | ||
| +0.42% | -0.78% | -17.81% | +4.86% | 3.15B | ||
| -0.35% | +3.98% | +2.25% | -27.01% | 1.95B | ||
| -1.30% | -3.79% | -22.50% | -26.51% | 1.68B | ||
| Average | +0.28% | -0.86% | +6.51% | +9.91% | 38.49B | |
| Weighted average by Cap. | +0.37% | -2.65% | +38.71% | +3.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 867M 748M 688M 647M 1.22B 81.85B 1.23B 8.15B 3.17B 40.17B 3.26B 3.19B 139B | 1.02B 880M 809M 761M 1.43B 96.25B 1.44B 9.59B 3.73B 47.24B 3.83B 3.75B 163B |
| Net income | 25.2M 21.74M 19.99M 18.81M 35.35M 2.38B 35.65M 237M 92.21M 1.17B 94.58M 92.55M 4.04B | 82.76M 71.4M 65.64M 61.78M 116M 7.81B 117M 778M 303M 3.83B 311M 304M 13.26B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-17 | 43.58 $ | 0.00% | 563,031 |
| 26-06-16 | 43.58 $ | -0.64% | 720,139 |
| 26-06-15 | 43.86 $ | -1.24% | 902,284 |
| 26-06-12 | 44.41 $ | -2.50% | 825,356 |
| 26-06-11 | 45.55 $ | +1.02% | 478,366 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPN Stock
Select your edition
All financial news and data tailored to specific country editions

















